Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Annalazole sodium vs rabeprazole for active duodenal ulcer (Phase II)
CTR20181468Phase 2Completed
- Sponsor
- Xuanzhu Biopharmaceutical
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anaprazole sodium in duodenal ulcer, sponsored by Xuanzhu Biopharmaceutical. Started Aug 2018; status: completed.
02
Drugs
anaprazole sodium
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on CTR20181468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181468.